UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by SJS Investment Consulting Inc.

SJS Investment Consulting Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.8% during the 1st quarter, HoldingsChannel reports. The firm owned 547 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. SJS Investment Consulting Inc.’s holdings in UnitedHealth Group were worth $286,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Piper Sandler reduced their price target on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a report on Tuesday, June 3rd. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. HSBC reiterated a “reduce” rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Truist Financial reiterated a “buy” rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $428.43.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $303.08 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a 50 day simple moving average of $404.62 and a 200-day simple moving average of $480.59. The firm has a market cap of $274.94 billion, a PE ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.

Insider Activity

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John H. Noseworthy acquired 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 in the last ninety days. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.